| Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ... JAMA neurology 76 (9), 1035-1048, 2019 | 544 | 2019 |
| Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders S Hall, A Öhrfelt, R Constantinescu, U Andreasson, Y Surova, F Bostrom, ... Archives of neurology 69 (11), 1445-1452, 2012 | 470 | 2012 |
| Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder O Hansson, S Janelidze, S Hall, N Magdalinou, AJ Lees, U Andreasson, ... Neurology 88 (10), 930-937, 2017 | 409 | 2017 |
| Cerebrospinal fluid inflammatory markers in Parkinson’s disease–associations with depression, fatigue, and cognitive impairment D Lindqvist, S Hall, Y Surova, HM Nielsen, S Janelidze, L Brundin, ... Brain, behavior, and immunity 33, 183-189, 2013 | 285 | 2013 |
| Non-motor symptoms in patients with Parkinson’s disease–correlations with inflammatory cytokines in serum D Lindqvist, E Kaufman, L Brundin, S Hall, Y Surova, O Hansson Public Library of Science 7 (10), e47387, 2012 | 244 | 2012 |
| Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease O Hansson, S Hall, A Öhrfelt, H Zetterberg, K Blennow, L Minthon, ... Alzheimer's research & therapy 6, 1-6, 2014 | 218 | 2014 |
| CSF biomarkers and clinical progression of Parkinson disease S Hall, Y Surova, A Öhrfelt, H Zetterberg, D Lindqvist, O Hansson Neurology 84 (1), 57-63, 2015 | 217 | 2015 |
| Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy M Wennström, Y Surova, S Hall, C Nilsson, L Minthon, F Boström, ... PloS one 8 (1), e53250, 2013 | 155 | 2013 |
| L ongitudinal M easurements of C erebrospinal F luid B iomarkers in P arkinson's D isease S Hall, Y Surova, A Öhrfelt, Swedish BioFINDER Study, K Blennow, ... Movement Disorders 31 (6), 898-905, 2016 | 149 | 2016 |
| Increased CSF biomarkers of angiogenesis in Parkinson disease S Janelidze, D Lindqvist, V Francardo, S Hall, H Zetterberg, K Blennow, ... Neurology 85 (21), 1834-1842, 2015 | 131 | 2015 |
| Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders S Hall, S Janelidze, Y Surova, H Widner, H Zetterberg, O Hansson Scientific reports 8 (1), 13276, 2018 | 118 | 2018 |
| The inflammatory marker YKL-40 is elevated in cerebrospinal fluid from patients with Alzheimer’s but not Parkinson’s disease or dementia with Lewy bodies M Wennström, Y Surova, S Hall, C Nilsson, L Minthon, O Hansson, ... PloS one 10 (8), e0135458, 2015 | 112 | 2015 |
| Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease JB Pereira, S Hall, M Jalakas, MJ Grothe, O Strandberg, E Stomrud, ... Neurobiology of disease 139, 104831, 2020 | 68 | 2020 |
| Swedish BioFINDER study. Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder O Hansson, S Janelidze, S Hall, N Magdalinou, AJ Lees, U Andreasson, ... Neurology 88 (10), 930-937, 2017 | 53 | 2017 |
| Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy E Kaufman, S Hall, Y Surova, H Widner, O Hansson, D Lindqvist PLoS One 8 (4), e62354, 2013 | 51 | 2013 |
| Swedish BioFINDER Study; Blennow, K.; Zetterberg, H.; Hansson, O. Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson’s Disease S Hall, Y Surova, A Öhrfelt Mov. Disord 31, 898-905, 2016 | 46 | 2016 |
| Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy Y Surova, M Nilsson, J Lätt, B Lampinen, O Lindberg, S Hall, H Widner, ... Neuroradiology 57, 1079-1091, 2015 | 44 | 2015 |
| Alterations of diffusion kurtosis and neurite density measures in deep grey matter and white matter in Parkinson’s disease Y Surova, B Lampinen, M Nilsson, J Lätt, S Hall, H Widner, ... PLoS One 11 (6), e0157755, 2016 | 42 | 2016 |
| Plasma Phospho‐tau identifies Alzheimer's co‐pathology in patients with Lewy body disease S Hall, S Janelidze, E Londos, A Leuzy, E Stomrud, JL Dage, O Hansson Movement Disorders 36 (3), 767-771, 2021 | 41 | 2021 |
| Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease S Hall, CD Orrù, GE Serrano, D Galasko, AG Hughson, BR Groveman, ... Acta neuropathologica communications 10 (1), 90, 2022 | 36 | 2022 |
